Newsletter

Exela Technologies Gets $90 Million Contract Award with Major US Health Insurer

Exela Technologies, Inc. (XELA) announced on March 9 that the company received a new $90 contract with a major US health insurance company. Exela Technologies is a global leader in business process automation and launched its PCH Global platform in September 2020 to combine its services with the power of automation technology and SaaS. This […]

0Comments

KemPharm gets FDA Approval for AZSTARYS™ to Treat ADHD

On March 2, KemPharm, Inc. (KMPH) announced that the FDA approved its New Drug Application (NDA) for the drug AZSTARYS™ (formerly referred to as KP415). The drug is a once-daily treatment for patients six-years-old and above who have attention deficit hyperactivity disorder (ADHD). AZSTARYS™ should be available as early as the second half of 2021 […]

0Comments

Latest of Knowledge Center

Latest of Newsletters